Svb Leerink Analyst Ratings & Stock Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Svb Leerink. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Svb Leerink.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
5/22/2019Svb LeerinkInitiatesRa Pharmaceuticals (RARX)Outperform $33.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/15/2019Svb LeerinkReiteratesHenry Schein (HSIC)Outperform -> Market Perform$75.00 -> $70.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/13/2019Svb LeerinkInitiatesHookipa Pharma (HOOK)Outperform $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/13/2019Svb LeerinkInitiatesTurning Point Therapeutics (TPTX)Outperform -> Outperform $42.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/13/2019Svb LeerinkInitiatesTandem Diabetes Care (TNDM)Outperform -> Outperform $83.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/7/2019Svb LeerinkDowngradesIntersect ENT (XENT)Outperform -> Market Perform$41.00 -> $29.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/7/2019Svb LeerinkReiteratesAdaptimmune Therapeutics (ADAP)Outperform -> Market Perform$12.00 -> $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2019Svb LeerinkReiteratesArcus Biosciences (RCUS)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
5/6/2019Svb LeerinkInitiatesAclaris Therapeutics (ACRS)Outperform $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2019Svb LeerinkUpgradesBruker (BRKR)Market Perform -> Outperform$40.00 -> $53.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/25/2019Svb LeerinkUpgradesNextgen Healthcare (NXGN)Market Perform -> Outperform$19.00 -> $22.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/24/2019Svb LeerinkInitiatesGENFIT S A/ADR (GNFT)Outperform -> Outperform $58.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/23/2019Svb LeerinkRaises TargetBiohaven Pharmaceutical (BHVN)Outperform$50.00 -> $67.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/17/2019Svb LeerinkRaises TargetAudentes Therapeutics (BOLD)Outperform$37.00 -> $48.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/15/2019Svb LeerinkInitiatesTocagen (TOCA)Mkt Perform -> Market Perform $11.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/15/2019Svb LeerinkReiteratesAduro BioTech (ADRO)Outperform -> Outperform $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/10/2019Svb LeerinkDowngradesPremier (PINC)Outperform -> Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
4/9/2019Svb LeerinkLowers TargetZogenix (ZGNX)Outperform -> Outperform$60.00 -> $48.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/9/2019Svb LeerinkRaises TargetAlnylam Pharmaceuticals (ALNY)Market Perform -> Market Perform$65.00 -> $70.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/8/2019Svb LeerinkInitiatesAxsome Therapeutics (AXSM)Outperform -> Outperform $25.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/29/2019Svb LeerinkUpgradesViking Therapeutics (VKTX)Market Perform -> Outperform$10.00 -> $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/28/2019Svb LeerinkInitiatesFate Therapeutics (FATE)Outperform $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/28/2019Svb LeerinkInitiatesAffimed (AFMD)Outperform $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/25/2019Svb LeerinkReiteratesresTORbio (TORC)OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
3/20/2019Svb LeerinkReiteratesCovetrus (CVET)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/19/2019Svb LeerinkReiteratesAurinia Pharmaceuticals (AUP)OutperformN/AView Rating Details  Share on Twitter  Share on StockTwits
3/18/2019Svb LeerinkReiteratesSynthorx (THOR)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/19/2019Svb LeerinkReiteratesVertex Pharmaceuticals (VRTX)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2019Svb LeerinkInitiatesNektar Therapeutics (NKTR)Mkt Perform $38.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/11/2019Svb LeerinkDowngradesAmerican Renal Associates (ARA)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
3/11/2019Svb LeerinkInitiatesTcr2 Therapeutics (TCRR)Outperform $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/11/2019Svb LeerinkInitiatesAvedro (AVDR)Outperform $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2019Svb LeerinkDowngradesAmneal Pharmaceuticals (AMRX)Outperform -> Market Perform$16.00 -> $12.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2019Svb LeerinkReiteratesSarepta Therapeutics (SRPT)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2019Svb LeerinkReiteratesHarpoon Therapeutics (HARP)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/5/2019Svb LeerinkDowngradesEndo International (ENDP)Outperform -> Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2019Svb LeerinkDowngradesbluebird bio (BLUE)Outperform -> Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2019Svb LeerinkDowngradesNightstar Therapeutics (NITE)Outperform -> Market Perform$35.00 -> $25.50LowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2019Svb LeerinkInitiatesGossamer Bio (GOSS)Outperform $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Svb LeerinkInitiatesMannKind (MNKD)Outperform $3.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Svb LeerinkInitiatesAlector (ALEC)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2019Svb LeerinkDowngradesImmunoGen (IMGN)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Svb LeerinkReiteratesRetrophin (RTRX)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
2/21/2019Svb LeerinkReiteratesCymaBay Therapeutics (CBAY)OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Svb LeerinkDowngradesClementia Pharmaceuticals (CMTA)Outperform -> Market Perform $26.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/25/2019Svb LeerinkDowngradesDiplomat Pharmacy (DPLO)Outperform -> Market Perform$24.00 -> $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Svb LeerinkInitiatesViking Therapeutics (VKTX)Mkt PerformLowView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Svb LeerinkInitiatesProvention Bio (PRVB)Outperform $6.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Svb LeerinkInitiatesMannKind (MNKD)Outperform $3.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Svb LeerinkInitiatesMadrigal Pharmaceuticals (MDGL)Outperform $165.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Svb LeerinkInitiatesGALAPAGOS NV/S (GLPG)OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Svb LeerinkReiteratesEquillium (EQ)Outperform $16.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Svb LeerinkInitiatesDermira (DERM)Outperform $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/22/2019Svb LeerinkDowngradesIntercept Pharmaceuticals (ICPT)Market Perform -> Underperform $70.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/15/2019Svb LeerinkReiteratesMirati Therapeutics (MRTX)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
2/14/2019Svb LeerinkReiteratesChemoCentryx (CCXI)OutperformN/AView Rating Details  Share on Twitter  Share on StockTwits
2/15/2019Svb LeerinkUpgradesAgios Pharmaceuticals (AGIO)Market Perform -> Outperform $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/8/2019Svb LeerinkDowngradesSolid Biosciences (SLDB)Outperform -> Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
2/7/2019Svb LeerinkUpgradesZafgen (ZFGN)Market Perform -> OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
2/6/2019Svb LeerinkReiteratesMarinus Pharmaceuticals (MRNS)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
1/30/2019Svb LeerinkDowngradesScpharmaceuticals (SCPH)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Sunday at 01:15 AM ET.

MarketBeat Community Rating for Svb Leerink

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  3,252 (Vote Outperform)
Underperform Votes:  3,397 (Vote Underperform)
Total Votes:  6,649
MarketBeat's community ratings are surveys of what our community members think about Svb Leerink and other research firms. Vote "Outperform" if you believe Svb Leerink's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Svb Leerink's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel